Endocrinology

Top Story

Multiple CGM systems provide comparable performance, usability

February 15, 2019

FDA approves interoperable insulin pump under new regulatory pathway

February 15, 2019
The FDA on Thursday approved marketing of the first insulin pump with interoperable technology for children and adults with diabetes, the first device to be classified…
In the Journals Plus

Serum catestatin may predict metabolic, CV risk in children, adolescents

February 15, 2019
Children and adolescents with obesity have lower levels of serum catestatin — an endogenous peptide found to be negatively associated with blood pressure level and…
In the Journals Plus

Type 2 diabetes weakens immune function

February 15, 2019
Adults with type 2 diabetes have lower natural killer cell activity compared with those with normal glucose tolerance or prediabetes, according to findings published in…

CAROLINA: Linagliptin demonstrates CV safety vs. sulfonylurea in type 2 diabetes

February 14, 2019
Top-line results from the CAROLINA study released Thursday demonstrated that the DPP-IV inhibitor linagliptin was noninferior vs. glimepiride for time to first major…
More Headlines »
ABIM MOC CME

Ace the Case: A 65-Year-Old Man with a History of Diabetes Mellitus, Hypertension, and Dyslipidemia

No commercial support for this activity.

This educational activity will discuss the management of dyslipidemia in a 65-year-old man with type 2 diabetes…
More »
Video
Meeting News

VIDEO: CV effects of vitamin D, omega-3 supplements remain unclear

November 24, 2018
More »
Resource Centers
ObesityWeek

ObesityWeek

ABIM MOC CME

Ace the Case: A 47-Year-Old Man with Concerns About His Weight

No commercial support for this activity.

This educational activity will utilize a case study to discuss the approach to the assessment and management of a…
More »
Current Issues
View the Current Issue